Concomitant use with CYP3A inducers is not recommended. Dosage must be adjusted with moderate or strong CYP3A inhibitors. Other drugs with the potential for interaction include: warfarin, digoxin, statins, glyburide, nateglinide, repaglinide.
Elexacaftor/tezacaftor/ivacaftor
Lumacaftor/ivacaftor
Beclometasone/formoterol/glycopyrronium bromide
Lifitegrast
Mometasone/formoterol
Beclometasone/formoterol
Budesonide/formoterol
Aclidinium bromide/formoterol